TABLE 1.
Results of the Comparison of Amplification Between OPN5 and 6p21.2 Genes
>2 |
>3 |
|||
---|---|---|---|---|
OPN5 | OPN5 | |||
2/573 (0.3%) | p, Chi-sq | 0 | p, Fisher | |
BTBD9 | 9/530 (1.7%) | 2.43E-02 | 2/530 (0.4%) | 1.42E-01 |
GLO1 | 49/536 (8.4%) | 2.59E-11 | 14/577 (2.4%) | 2.10E-04 |
DNAH8 | 30/568 (5.0%) | 9.70E-07 | 5/595 (0.8%) | 2.85E-02 |
GLP1R | 26/532 (4.7) | 3.41E-06 | 7/551 (1.3%) | 7.16E-03 |
C6orf64 | 16/589 (2.6%) | 1.34E-03 | 3/602 (0.5%) | 9.15E-02 |
KCNK5 | 15/557 (2.6%) | 1.45E-03 | 2/570 (0.3%) | 1.58E-01 |
KCNK17 | 26/520 (4.8%) | 1.32E-06 | 5/541 (0.9%) | 2.19E-02 |
KCNK16 | 11/546 (2.0%) | 1.02E-02 | 3/554 (0.5%) | 1.33E-02 |
C6orf102 | 7/576 (1.2%) | 9.90E-02 | 2/586 (0.3%) | 1.63E-01 |
DAAM2 | 8/598 (1.3%) | 6.83E-02 | 3/604 (0.5%) | 5.18E-02 |
In this table the frequencies of amplification (for threshold of >2-fold and >3-fold) of genes mapping to the amplicon on 6p21.2 are listed together with the statistical significance of the difference between amplification frequencies of OPN5 and respective genes. P-values significant after Benjamini-Hochberg correction with a FDR of 10% are indicated in bold. The amplification frequencies were calculated as ratios of the number of samples with amplification confirmed in two independent experiments and the total number of informative samples.